Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast

Breast Cancer Research and Treatment

Volumn 145, Issue 3, 2014, Pages 765-773

  Houssami, Nehmat ^a   Abraham, Linn A ^b   Onega, Tracy ^c   Collins, Laura C ^d   Sprague, Brian L ^e   Hill, Deirdre A ^f   Miglioretti, Diana L ^b,g  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CENTER FOR HEALTH STUDIES   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atypical hyperplasia; High risk screening; Interval cancer; Lobular carcinoma in situ; Mammography

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL HYPERPLASIA; ATYPICAL LOBULAR HYPERPLASIA; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; CANCER INCIDENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FAMILY HISTORY; FEMALE; HUMAN; LOBULAR CARCINOMA IN SITU; MAMMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BREAST; BREAST NEOPLASMS; CARCINOMA, LOBULAR; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCEROUS CONDITIONS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, LOBULAR; DIAGNOSTIC ERRORS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; HYPERPLASIA; MAMMOGRAPHY; MIDDLE AGED; PRECANCEROUS CONDITIONS; YOUNG ADULT;

EID: 84901623878     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2965-z     Document Type: Article

References (20)

1. Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75-89
2. Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905-1917
3. Lakhani SR, Audretsch W, Cleton-Jensen AM et al (2006) The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer 42(14):2205-2211
4. Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105(14):1043-1049
5. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer 109(2):180-187
6. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.[Erratum appears in Lancet. 2003 Jun 7; 361(9373):1994]. Lancet 361(9352):125-129
7. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22(12):1232-1239
8. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146-151
9. Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 20(8):723-725
10. Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261(2):414-420
11. Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261(2):421-427
12. Port ER, Park A, Borgen PI, Morris E, Montgomery LL (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14(3):1051-1057
13. Ballard-Barbash R, Taplin SH, Yankaskas BC et al (1997) Breast cancer surveillance consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169(4):1001-1008
14. Houssami N, Ciatto S, Ellis I, Ambrogetti D (2007) Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 109(3):487-495
15. Yankaskas BC, Taplin SH, Ichikawa L et al (2005) Association between mammography timing and measures of screening performance in the United States. Radiology 234(2):363-373
16. Rosenberg RD, Yankaskas BC, Abraham LA et al (2006) Performance benchmarks for screening mammography. Radiology 241(1):55-66
17. American College of Radiology (ACR) (2003) Breast imaging reporting and data system (BI-RADS), 4th edn. American College of Radiology, Reston
18. Visvanathan K, Hurley P, Bantug E et al (2013) Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(23):2942-2962
19. King TA, Muhsen S, Patil S et al (2013) Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat 142(2):445-453
20. Taplin SH, Abraham L, Geller BM et al (2010) Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst 102(14):1040-1051